Our website uses cookies to make navigation as functional as possible and to perform statistics on its usage. Should you wish to receive more information, or deny your consent to all or some of the cookies, please click here. By continuing to browse this website, you will be accepting our cookies.
Press Release
Page Available only in italian language
Press Release
Page Available only in italian language
Press Release
Page available only in italian language 
Press Release
Press Release
Page available only in italian language
The Menarini Group announces meropenem/vaborbactam European marketing authorization
Meropenem/vaborbactam approved on 20th November 2018 by the European Commission for clinical use in adult patients with difficult-to-treat infections. The first combination of a carbapenem and a beta-lactamase inhibitor...
Page 4 of 5First   Previous   1  2  3  [4]  5  Next   Last